Determinant of the effectiveness of GLP-1 in type 2 diabetes

被引：0
|
作者：
Toft-Nielsen, MB
Madsbad, S
Damholt, MB
Holst, JJ
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
516
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [31] IN TYPE 2 DIABETES MELLITUS THE GLP-1 EFFECTS ON PLATELETS ARE IMPAIRED
    Barale, C.
    Frascaroli, C.
    Cavalot, F.
    Guerrasio, A.
    Russo, I.
    ATHEROSCLEROSIS, 2016, 252 : E257 - E258
  • [32] Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
    Salehi, Marzieh
    Aulinger, Benedict
    Prigeon, Ronald L.
    D'Alessio, David A.
    DIABETES, 2010, 59 (06) : 1330 - 1337
  • [33] Liraglutide: A human GLP-1 analogue for the treatment of type 2 diabetes
    Sakauye, Stacie D.
    Shah, Sachin A.
    FORMULARY, 2009, 44 (05) : 136 - +
  • [34] GLP-1 engineering in yeast for the Type 2 diabetes treatment.
    Egel-Mitani, M
    Nielsen, PF
    YEAST, 2003, 20 : S313 - S313
  • [35] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [36] GLP-1 Agonists: Improving the Future of Patients With Type 2 Diabetes
    Shubrook, Jay H.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (02): : ESII - ES1
  • [37] The role of GLP-1 in the enteroinsulinar axis in type 2 diabetes mellitus
    Bedorf, A.
    Kutscherauer, G.
    Nicolaus, M.
    Goeke, B.
    Schirra, J.
    DIABETOLOGIA, 2009, 52 : S106 - S106
  • [38] The evolving world of GLP-1 agonist therapies for type 2 diabetes
    Baynes, Kevin C. R.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (02) : 61 - 67
  • [39] Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes
    St Onge, Erin L.
    Miller, Shannon A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (05) : 801 - 806
  • [40] Additive effects of GLP-1 and pioglitazone in patients with type 2 diabetes
    Zander, M
    Christiansen, A
    Madsbad, S
    Holst, JJ
    DIABETES, 2004, 53 : A342 - A342
12345